Sumavel dosepro and Injection site extravasation - a phase IV clinical study of FDA data

Summary:

Injection site extravasation is reported as a side effect among people who take Sumavel dosepro (sumatriptan succinate), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Topamax, and have Migraine.

The phase IV clinical study analyzes which people have Injection site extravasation when taking Sumavel dosepro. It is created by eHealthMe based on reports of 1,274 people who have side effects when taking Sumavel dosepro from the FDA, and is updated regularly.

What is Sumavel dosepro?

Sumavel dosepro has active ingredients of sumatriptan succinate. eHealthMe is studying from 1,276 Sumavel dosepro users. Check the latest studies of Sumavel dosepro.

What is Injection site extravasation?

Injection site extravasation (flow of (blood or lymph) from injection site) is found to be associated with 555 drugs and 730 conditions by eHealthMe. Check the latest studies of Injection site extravasation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

1,274 people reported to have side effects when taking Sumavel dosepro.
Among them, 14 people (1.1%) have Injection site extravasation.

Could Sumavel dosepro cause Injection site extravasation?

Among these 14 people:

How long have people been on Sumavel dosepro when they have Injection site extravasation? *

What is the gender of people who have Injection site extravasation when taking Sumavel dosepro? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Injection site extravasation when taking Sumavel dosepro? *

What are other drugs people take besides Sumavel dosepro? *

What are other side effects people have besides Injection site extravasation? *

Injection Site Pain: 4 people, 28.57%
Injection Site Haemorrhage (bleeding from injection site): 4 people, 28.57%
Injection Site Bruising: 3 people, 21.43%
Injection Site Swelling: 2 people, 14.29%
Drug Ineffective: 2 people, 14.29%
Weight Increased: 1 person, 7.14%
Weight Decreased: 1 person, 7.14%
Speech Impairment (Adult) (inability to speak (adult)): 1 person, 7.14%
Injection Site Urticaria (rash of round, red welts on the skin at injection site): 1 person, 7.14%
Injection Site Induration: 1 person, 7.14%

What are the existing conditions these people have? *

Migraine (headache): 14 people, 100.00%
Depression: 3 people, 21.43%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 7.14%
Stress And Anxiety: 1 person, 7.14%
Pain: 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Breast Cancer: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sumavel dosepro and have Injection site extravasation?

- Check whether Injection site extravasation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumavel dosepro:

Sumavel dosepro (1,276 reports)

Browse all side effects of Sumavel dosepro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site extravasation:

Injection site extravasation (555 drugs)

Browse all the conditions that are associated with Injection site extravasation:

Injection site extravasation (730 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumavel dosepro) and Sumavel dosepro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.